Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Annexon Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Jasper Therapeutics Inc. July 31, 202695.7%
-
Pacira BioSciences Inc. June 9, 202685.9%
-
Annexon Inc. June 8, 202374.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2025 | Jasper Therapeutics Inc. | Open-market purchase | +41,000 | $2.43 | $99,630 |
| Nov 28, 2023 | Jasper Therapeutics Inc. | Open-market purchase | +10,000 | $0.65 | $6,500 |
| Nov 21, 2023 | Jasper Therapeutics Inc. | Open-market purchase | +10,000 | $0.64 | $6,400 |
| Nov 20, 2023 | Jasper Therapeutics Inc. | Open-market purchase | +10,000 | $0.63 | $6,300 |
| Nov 17, 2023 | Jasper Therapeutics Inc. | Open-market purchase | +10,000 | $0.60 | $6,000 |
| Nov 16, 2023 | Jasper Therapeutics Inc. | Open-market purchase | +10,000 | $0.60 | $6,000 |
Questions about Thomas G. Wiggans
What boards is Thomas G. Wiggans on?
Thomas G. Wiggans sits on the boards of Annexon Inc., Jasper Therapeutics Inc. and Pacira BioSciences Inc.
How long has Thomas G. Wiggans served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.